CELTIC-19 – Ixaka’s targeted nanoparticle for CD19 haematological malignancies – has been granted Advanced Therapy Medicinal Product (ATMP) classification by the European Medicines Agency (EMA). The ...
The study of medicinal plants represents a vital interdisciplinary field at the intersection of traditional botanical knowledge and modern life sciences. In ...
Ocugen, Inc. has announced that the European Commission has given a positive opinion for the classification of its gene therapy product, OCU400, as an Advanced Therapy Medicinal Product (ATMP) by the ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological disorders, today announced that ...
The San Diego Botanic Garden in Encinitas is leading an effort to turn plants into better medicines. KPBS sci-tech reporter Thomas Fudge explains what we already know about herbal remedies — and what ...
(RTTNews) - Ocugen, Inc. (OCGN) Monday said that the European Medicines Agency's (EMA) Committee for Advanced Therapies (CAT) has provided a positive opinion for Advanced Therapy Medicinal Product ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results